MO · NYSE · CIK 0000764180
Altria Group, Inc.
Altria Group, Inc. holds 3 disclosed positions, 2 of them carrying a sourced value and 1 that nobody has sized.
Altria Group, Inc. - Profile
- Sector
- Consumer StaplesGICS
- Industry
- CigarettesSIC 2111
- Listed on
- NYSE
- Employees
- 9,900date not stated
- Incorporated in
- Virginia
- Financial year ends
- 31 December
Source
Address, industry classification, listing and incorporation come from Altria Group, Inc.'s own SEC filer record, so the industry is the SEC's dry classification rather than a marketing label. The website comes from Wikidata. The headcount is the figure Wikidata carries, undated, not a figure this site has verified against a filing. The description is the opening paragraph of its Wikipedia article, used under CC BY-SA 4.0.
Share price
MO
Description
Altria Group, Inc. is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and medical products in the treatment of illnesses caused by tobacco. It operates worldwide and is headquartered in the city of Richmond, Virginia.
Equity stakes Altria Group, Inc. holds in other companies.
modelled, reported or pending
Select a row or a slice for its provenance: the filing it came from, when it was measured, and the arithmetic behind it if it was modelled.
The full register, from 13F filings
The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 2,449 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.
2,449 managers reported a position, together holding 1.03bn shares, or 61.7% of the company. The 40 largest are listed. Percentages are of the 1.67bn shares outstanding at 22 Apr 2026, the count in force when this quarter was measured rather than the count today.
Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.
What a reader needs to know to read these numbers
- Altria does not file Form 13F; it is an operating company, not an institutional investment manager.
- Philip Morris International (PMI) is deliberately excluded from holdings. PMI was spun off from Altria in 2008 into a fully separate, independently listed company. The FY2025 10-K and Q2 FY2026 10-Q were both checked and contain no equity holding, investment, or ownership stake by Altria in PMI: the relationship is limited to licensing (Altria licenses certain heated-tobacco and e-vapor IP to and from PMI under commercial agreements described in the 10-K), not a shareholding. This is the expected null result described in the brief, not a gap.
- NJOY Holdings, Inc. is excluded from holdings as instructed by the brief: it was acquired outright by Altria (closed June 2023) and is a wholly owned consolidated subsidiary, not a minority stake. The FY2025 10-K discusses NJOY-related contingent payments and litigation but these are subsidiary matters, not an equity-method investment.
- Coca-Cola Consolidated-style CUSIP confusion does not apply here: Altria's own stock has a single CUSIP (02209S103) and every register row above is filtered to that CUSIP.
- value_usd for the ABI and Cronos holdings is FAIR VALUE (quoted market value), the more decision-useful and market-comparable figure, per the brief's request to state which measure is used. Altria's filings separately disclose CARRYING VALUE (equity-method book value) for both, which is materially lower: ABI carrying value $8.6 billion vs fair value $13.2 billion at 30 Jun 2026 (carrying value is about 65 percent of fair value); Cronos carrying value $319 million vs fair value $432 million at the same date (about 74 percent). Both carrying values are recorded in each holding's method_note rather than in value_usd.
- JUUL is recorded as a holding with shares 0 and value_usd 0 rather than omitted, per the brief's rule that a sourced zero is still a finding. This is a full divestment (March 2023 Stock Transfer Agreement, all equity transferred to JUUL for an IP license), not merely a heavy write-down to a low but nonzero figure as the brief's framing suggested it might be; the current filings are unambiguous that Altria holds no JUUL equity at all.
- Two register rows (BlackRock, State Street relative to the proxy's threshold) disagree with, or are entirely absent from, Altria's own 2026 proxy 5-percent-holder table because that table is anchored to stale Schedule 13G/A filings (BlackRock's dated 31 Dec 2023) rather than current 13F data; both disagreements are recorded with both figures in the relevant row's method_note per the brief's reconcile-do-not-overwrite rule, consistent with the Broadcom and Coca-Cola reference files for this project.
- Register percentages use two different denominators: institutional (13F) rows use 1,669,743,926 shares outstanding as of 22 Jul 2026 (Q2 FY2026 10-Q cover page); the three proxy-sourced insider rows use 1,671,313,564 shares, the proxy's own record-date (25 Mar 2026) denominator, because that is the number the proxy itself would use and the individual insider share counts are dated 27 Feb 2026, closer to the record date than to the 10-Q cover date. The two denominators differ by about 1.6 million shares (roughly 0.1 percent) and are about two months apart.
- No em dashes are used anywhere in this file per the brief's house style.
Looked for, not found
Recorded rather than filled in. Each of these is a place where a number could have been invented and was not.
- Exact per-share fair value (price) used to derive the ABI and Cronos fair-value figures. The 10-Q states aggregate fair value in billions/millions and states approximate share counts, but does not itself state a per-share price, so value_price_per_share is left null for both rather than back-calculated and presented as filed.
- ABI's and Cronos's own total shares outstanding (the denominators for Altria's stated ownership percentages). Neither Altria's 10-K nor 10-Q discloses the investee's total share count; only Altria's own approximate share count and resulting ownership percentage are given. Checked both the FY2025 10-K and Q2 FY2026 10-Q full text for a total-shares figure for either investee and found none.
- The exact calendar day in March 2023 that the JUUL Stock Transfer Agreement was executed. The FY2025 10-K states only 'In March 2023' in two separate passages; no more precise date was found within the time budget. A JUUL-specific 8-K from March 2023, which would likely carry the exact date, was not checked.
- Any Schedule 13D or fresh 13G/A filed directly by a third party against Altria common stock more recent than BlackRock's 26 Jan 2024 13G/A (the one the proxy itself cites). Checked Altria's own EDGAR filing history for SC 13D and SC 13G filings under CIK 0000764180 and found only (a) filings where Altria itself is the reporting person on ABI, and (b) BlackRock's 2022-2024 vintage 13G/A filings on Altria stock; no more recent third-party 13D/G on Altria stock was found, consistent with no activist or control-seeking holder being present.
- Capital Research/Capital Group, T. Rowe Price, Norges Bank (Norway's sovereign wealth fund) and any other sub-13F or sovereign holder of Altria stock. Not checked in this task; the register was capped at the 7 institutional 13F filers named in the brief by CIK (Vanguard, BlackRock, State Street, Geode, FMR, Morgan Stanley, JPMorgan) plus 3 insider rows from the proxy, which together cover roughly 26.7 percent of shares outstanding, to stay within the time budget.
- Precise, current-quarter market capitalization. The $109.7 billion figure is read from stockanalysis.com's live overview page (not a filing) and is dated to the day this research was performed (17 Aug 2026); it is an aggregator figure, basis 'aggregator', not independently verified against a specific closing price and share count on that date.
- Whether Altria's Q3 FY2026 10-Q (covering the quarter ending on or about 30 Sep 2026) has been filed. As of this research (17 Aug 2026) it had not yet appeared in the EDGAR submissions feed for CIK 0000764180, so the Q2 FY2026 10-Q (period ended 30 Jun 2026) is the most current filing used throughout.